APA (7th ed.) Citation

JS, E., A, H., G, M., D, B., R, G., S, A., & EB, S. (2017). Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis. Clinical and translational science, 10(1), 28. https://doi.org/10.1111/cts.12428

Chicago Style (17th ed.) Citation

JS, Elborn, Horsley A, MacGregor G, Bilton D, Grosswald R, Ahuja S, and Springman EB. "Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis." Clinical and Translational Science 10, no. 1 (2017): 28. https://doi.org/10.1111/cts.12428.

MLA (9th ed.) Citation

JS, Elborn, et al. "Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis." Clinical and Translational Science, vol. 10, no. 1, 2017, p. 28, https://doi.org/10.1111/cts.12428.